Year archive

Bavarian Nordic — 2022 filings

All 151 regulatory filings released by Bavarian Nordic (BAVA) in 2022, sourced directly from the official regulator.

151 Filings

2022 Period

2022 filings (151)

Filing	Released	Lang
Regulatory Filings 2022 Regulatory Filings	2022-12-23	English
Regulatory Filings 2022 Regulatory Filings	2022-12-23	Danish
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine Regulatory Filings	2022-12-23	Danish
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine Regulatory Filings	2022-12-23	Danish
Director's Dealing 2022 Director's Dealing	2022-12-08	Danish
Director's Dealing 2022 Director's Dealing	2022-12-08	English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-12-08	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-12-08	Danish
Director's Dealing 2022 Director's Dealing	2022-11-24	Danish
Director's Dealing 2022 Director's Dealing	2022-11-24	English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-11-24	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-11-24	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-23	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-23	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-23	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-23	Danish
Regulatory Filings 2022 Regulatory Filings	2022-11-17	English
Legal Proceedings Report 2022 Legal Proceedings Report	2022-11-17	Danish
Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines Regulatory Filings	2022-11-17	Danish
Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines Regulatory Filings	2022-11-17	Danish
Regulatory Filings 2022 Regulatory Filings	2022-10-17	Danish
Regulatory Filings 2022 Regulatory Filings	2022-10-17	English
Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial Regulatory Filings	2022-10-17	Danish
Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial Regulatory Filings	2022-10-17	English
Board/Management Information 2022 Board/Management Information	2022-09-20	Danish
Board/Management Information 2022 Board/Management Information	2022-09-20	English
Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic Board/Management Information	2022-09-20	Danish
Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic Board/Management Information	2022-09-20	English
Regulatory Filings 2022 Regulatory Filings	2022-09-20	Danish
Regulatory Filings 2022 Regulatory Filings	2022-09-20	English
Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada Regulatory Filings	2022-09-20	Danish
Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada Regulatory Filings	2022-09-20	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-07	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-07	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-07	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-07	Danish
Earnings Release 2022 Earnings Release FY 2022	2022-09-07	English
Earnings Release 2022 Earnings Release FY 2022	2022-09-07	Danish
Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) Regulatory Filings	2022-09-07	Danish
Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) Regulatory Filings	2022-09-07	Danish
Regulatory Filings 2022 Regulatory Filings	2022-09-02	Danish
Regulatory Filings 2022 Regulatory Filings	2022-09-02	English
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate Regulatory Filings	2022-09-02	Danish
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate Regulatory Filings	2022-09-02	English
Report Publication Announcement 2022 Report Publication Announcement H1 2022	2022-08-24	Danish
Earnings Release 2022 Earnings Release H1 2022	2022-08-24	English
Bavarian Nordic Announces First Half 2022 Results Interim / Quarterly Report H1 2022	2022-08-24	English
Bavarian Nordic Announces First Half 2022 Results Report Publication Announcement H1 2022	2022-08-24	Danish
Regulatory Filings 2022 Regulatory Filings	2022-08-03	Danish
Regulatory Filings 2022 Regulatory Filings	2022-08-03	English
Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023 Regulatory Filings	2022-08-03	Danish
Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023 Regulatory Filings	2022-08-03	Danish
Regulatory Filings 2022 Regulatory Filings	2022-07-22	Danish
Regulatory Filings 2022 Regulatory Filings	2022-07-22	English
Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox Regulatory Filings	2022-07-22	Danish
Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox Regulatory Filings	2022-07-22	Danish
Environmental & Social Information 2022 Environmental & Social Information	2022-07-19	English
Regulatory Filings 2022 Regulatory Filings	2022-07-19	Danish
Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023 Regulatory Filings	2022-07-19	Danish
Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023 Regulatory Filings	2022-07-19	Danish
Share Issue/Capital Change 2022 Share Issue/Capital Change	2022-07-18	Danish
Earnings Release 2022 Earnings Release FY 2022	2022-07-18	English
Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak Earnings Release FY 2022	2022-07-18	Danish
Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak Regulatory Filings	2022-07-18	English
Earnings Release 2022 Earnings Release FY 2022	2022-07-15	English
Regulatory Filings 2022 Regulatory Filings	2022-07-15	Danish
U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic Regulatory Filings	2022-07-15	Danish
U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic Regulatory Filings	2022-07-15	Danish
Environmental & Social Information 2022 Environmental & Social Information	2022-07-01	English
Regulatory Filings 2022 Regulatory Filings	2022-07-01	Danish
U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic Regulatory Filings	2022-07-01	Danish
U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic Regulatory Filings	2022-07-01	English
Regulatory Filings 2022 Regulatory Filings	2022-06-14	Danish
Earnings Release 2022 Earnings Release FY 2022	2022-06-14	English
Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak Regulatory Filings	2022-06-14	Danish
Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak Regulatory Filings	2022-06-14	English
Earnings Release 2022 Earnings Release FY 2022	2022-06-10	Danish
Earnings Release 2022 Earnings Release FY 2022	2022-06-10	English
Bavarian Nordic Receives an Additional Order for JYNNEOS Smallpox and Monkeypox Vaccine from the U.S. Government Earnings Release FY 2022	2022-06-10	Danish
Bavarian Nordic Receives an Additional Order for JYNNEOS Smallpox and Monkeypox Vaccine from the U.S. Government Regulatory Filings	2022-06-10	English
Regulatory Filings 2022 Regulatory Filings	2022-06-07	Danish
Capital/Financing Update 2022 Capital/Financing Update	2022-06-07	English
Bavarian Nordic Enters a New Multi-Year Vaccine Contract with the Government of Canada Regulatory Filings	2022-06-07	Danish
Bavarian Nordic Enters a New Multi-Year Vaccine Contract with the Government of Canada Regulatory Filings	2022-06-07	English
Earnings Release 2022 Earnings Release FY 2022	2022-05-30	English
Regulatory Filings 2022 Regulatory Filings	2022-05-30	Danish
Bavarian Nordic Enters Additional Vaccine Contracts with Governments in Response to Monkeypox Outbreak Earnings Release FY 2022	2022-05-30	Danish
Bavarian Nordic Enters Additional Vaccine Contracts with Governments in Response to Monkeypox Outbreak Regulatory Filings	2022-05-30	English
Earnings Release 2022 Earnings Release FY 2022	2022-05-25	English
Earnings Release 2022 Earnings Release FY 2022	2022-05-25	Danish
Bavarian Nordic Enters First Larger Vaccine Contract with Government in Response to Monkeypox Outbreak Earnings Release FY 2022	2022-05-25	Danish
Bavarian Nordic Enters First Larger Vaccine Contract with Government in Response to Monkeypox Outbreak Regulatory Filings	2022-05-25	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-23	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-23	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-23	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-23	Danish
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-18	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-18	Danish
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program Transaction in Own Shares	2022-05-18	English
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program Transaction in Own Shares	2022-05-18	English
Regulatory Filings 2022 Regulatory Filings	2022-05-18	Danish
Capital/Financing Update 2022 Capital/Financing Update	2022-05-18	English
Bavarian Nordic to Manufacture First Freeze-dried Doses of Smallpox Vaccine upon Exercise of Contract Option by the U.S. Government Regulatory Filings	2022-05-18	Danish
Bavarian Nordic to Manufacture First Freeze-dried Doses of Smallpox Vaccine upon Exercise of Contract Option by the U.S. Government Regulatory Filings	2022-05-18	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-09	Danish
Transaction in Own Shares 2022 Transaction in Own Shares	2022-05-09	English
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations Transaction in Own Shares	2022-05-09	Danish
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations Transaction in Own Shares	2022-05-09	English
Earnings Release 2022 Earnings Release FY 2022	2022-05-05	Danish
Regulatory Filings 2022 Regulatory Filings	2022-05-05	English
Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate Regulatory Filings	2022-05-05	Danish
Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate Regulatory Filings	2022-05-05	English
Remuneration Information 2022 Remuneration Information	2022-04-29	English
Director's Dealing 2022 Director's Dealing	2022-04-29	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-04-29	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-04-29	English
Director's Dealing 2022 Director's Dealing	2022-04-24	English
Director's Dealing 2022 Director's Dealing	2022-04-24	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-04-24	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-04-24	English
Regulatory Filings 2022 Regulatory Filings	2022-04-20	Danish
Investor Presentation 2022 Investor Presentation	2022-04-20	English
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults Regulatory Filings	2022-04-20	Danish
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults Regulatory Filings	2022-04-20	English
Remuneration Information 2022 Remuneration Information	2022-04-01	Danish
Director's Dealing 2022 Director's Dealing	2022-04-01	English
New Incentive Programs Established for Members of Executive and Other Management in Bavarian Nordic Director's Dealing	2022-04-01	Danish
New Incentive Programs Established for Members of Executive and Other Management in Bavarian Nordic Director's Dealing	2022-04-01	Danish
Regulatory Filings 2022 Regulatory Filings	2022-03-21	Danish
Capital/Financing Update 2022 Capital/Financing Update	2022-03-21	English
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian M Regulatory Filings	2022-03-21	Danish
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian M Regulatory Filings	2022-03-21	Danish
Director's Dealing 2022 Director's Dealing	2022-03-21	English
Director's Dealing 2022 Director's Dealing	2022-03-21	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-03-21	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-03-21	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-03-18	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-03-18	Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-03-18	English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-03-18	Danish
Director's Dealing 2022 Director's Dealing	2022-03-04	Danish
Director's Dealing 2022 Director's Dealing	2022-03-04	English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-03-04	Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such Director's Dealing	2022-03-04	English
Annual Report 2021 Annual Report FY 2021	2022-03-04	English
Annual Report 2021 Annual Report FY 2021	2022-03-04	English
Annual Report 2021 Annual Report FY 2021	2022-03-04	English
Report Publication Announcement 2022 Report Publication Announcement	2022-03-04	English
Bavarian Nordic Publishes Annual Report 2021 Report Publication Announcement	2022-03-04	Danish
Bavarian Nordic Publishes Annual Report 2021 Report Publication Announcement	2022-03-04	Danish
Bavarian Nordic Publishes Annual Report 2021 Report Publication Announcement	2022-03-04	English

Filings by year

2026 120 filings
2025 198 filings
2024 138 filings
2023 143 filings
2022 151 filings
2021 150 filings
2020 185 filings
2019 113 filings
2018 115 filings
2017 179 filings
2016 160 filings
2015 96 filings
2014 83 filings
2013 73 filings
2012 57 filings
2011 122 filings
2010 141 filings
2009 63 filings
2008 6 filings